The “Expert consensus on inhalation therapy for common respiratory diseases in children” (39) and the “Guidelines for standardized management of children's inhalation centers” (40) indicate that IFN-α is a commonly used antiviral drug and has a history of clinical application. Here, IFNA1 is linked to respiratory system disorder.